Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
138 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Rank Status Study
21 Recruiting Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
Condition: Malaria
Interventions: Drug: Monthly Sulfadoxine-Pyrimethamine (SP) During Pregnancy;   Drug: Monthly Dihydroartemisinin-Piperaquine (DP) During Pregnancy
22 Not yet recruiting Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
Condition: Malaria
Intervention:
23 Recruiting Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers
Condition: Malaria
Interventions: Drug: Arterakine (DHA/piperaquine);   Drug: Placebo
24 Not yet recruiting A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)
Condition: Uncomplicated Malaria
Interventions: Drug: PQ supervised;   Drug: PQ unsupervised
25 Recruiting MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B
Condition: Malaria
Interventions: Drug: MMV390048 40mg;   Drug: MMV390048 dose to be determined mg
26 Recruiting Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A
Condition: Malaria
Interventions: Drug: MMV390048 40 mg;   Drug: Placebo to match MMV390048 40 mg;   Drug: MMV390048 80 mg;   Drug: Placebo to match MMV390048 80 mg;   Drug: MMV390048 120 mg;   Drug: Placebo to match MMV390048 120 mg
27 Recruiting PfSPZ Challenge in Non-immune Adults in Baltimore, USA
Condition: Plasmodium Falciparum Infection
Interventions: Biological: PfSPZ (NF54);   Biological: PfSPZ (7G8)
28 Recruiting PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
Condition: Plasmodium Falciparum Infection
Interventions: Drug: Chloroquine;   Other: Placebo;   Biological: PfSPZ
29 Recruiting Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicity
Condition: Malaria Transmission
Interventions: Other: Pre-treatment follow up;   Other: S. haematobium treatment;   Other: Post treatment follow up;   Other: Olfactometer experiment
30 Recruiting Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)
Condition: Malaria
Intervention: Biological: Plasmodium falciparum sporozoite (PfSPZ)
31 Recruiting Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar
Conditions: Malaria;   Plasmodium Infections
Intervention: Drug: MDA with DHAp and SLD Primaquine
32 Recruiting Sequential Optimization of Dose and Schedule of PfSPZ Vaccine
Condition: Malaria
Interventions: Biological: PfSPZ Vaccine;   Biological: PfSPZ Challenge (NF54);   Biological: PfSPZ Challenge (7G8);   Other: Normal saline
33 Not yet recruiting Low Resource Diagnostics Development Cohort - VZNIGHT
Condition: Malaria
Intervention: Other: No Intervention / Not Applicable
34 Not yet recruiting Methylene Blue Against Vivax Malaria in Ethiopia
Condition: Vivax Malaria
Interventions: Drug: Artemeter-Lumefantrine and MB (combination therapy);   Drug: Artemeter-Lumefantrine (combination therapy);   Drug: Artemeter-Lumefantrine and Primaquine (combination therapy)
35 Recruiting Rosiglitazone Adjunctive Therapy for Severe Malaria in Children
Condition: Malaria
Interventions: Drug: Rosiglitazone;   Drug: Placebo
36 Recruiting Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya
Condition: Malaria
Interventions: Biological: PfSPZ Vaccine;   Other: Normal Saline
37 Recruiting Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region
Condition: Tropical Infectious Diseases
Intervention: Other: None, treatment as actual best practice
38 Recruiting Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso
Condition: Plasmodium Falciparum Infection
Interventions: Biological: PfSPZ;   Other: Placebo;   Drug: Artesunate
39 Recruiting Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine 150 mg;   Drug: Matched placebo 150mg
40 Recruiting Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults
Condition: Malaria
Interventions: Biological: PRIMVAC;   Biological: GLA-SE;   Biological: Alhydrogel;   Biological: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.